Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Amlodipine Besylate

SKU: orb1226970

Description

Amlodipine Besylate is a long-acting calcium channel blocker.(In Vitro):Amlodipine besylate (20-40 μM; 48 h) reduces BrdU incorporation to 68.6% and 26.3% at concentrations of 20 and 30 μM in A431 cells, respectively.Amlodipine besylate (30 μM; pretreated for 1 h) significantly attenuates the uridine 5′-triphosphate (UTP)-induced increases of [Ca2+]i in A431 cells.Amlodipine besylate (30 μM) inhibits the store-operated Ca2+influx evoked by Thapsigargin in Fluo-3-loaded cells.(In Vivo):Amlodipine besylate (5 mg/kg/day; s.c. for 2 weeks) significantly decreases systolic blood pressure (SBP) in VSMC ATP2B1 KO mice.Amlodipine besylate (10 mg/kg; i.p. once daily for 20 days) causes a significant retardation of tumor growth and prolongs the survival of A431 tumor-bearing mice.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number111470-99-6
MW567.05
Purity>98% (HPLC)
FormulaC26H31ClN2O8S
SMILESO=C(C1=C(COCCN)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2Cl)OCC.O=S(C3=CC=CC=C3)(O)=O
TargetCalcium Channel
SolubilityEthanol: 14 mg/mL (24.68 mM); DMSO: 113 mg/mL (199.27 mM)

Bioactivity

In Vivo
Amlodipine besylate (5 mg/kg/day; s. c. for 2 weeks) significantly decreases systolic blood pressure (SBP) in VSMC ATP2B1 KO mice. Amlodipine besylate (10 mg/kg; i.p. once daily for 20 days) causes a significant retardation of tumor growth and prolongs the survival of A431 tumor-bearing mice. Animal model: ATP2B1loxP/loxP mice. Dosage: 5 mg/kg/day. Administration: Subcutaneously implanted osmotic pump for 2 weeks. Result: Significantly decreased the blood pressure.
In Vitro
Amlodipine besylate (20-40 μM; 48 h) reduces BrdU incorporation to 68.6% and 26.3% at concentrations of 20 and 30 μM in A431 cells, respectively. Amlodipine besylate (30 μM; pretreated for 1 h) significantly attenuates the uridine 5′-triphosphate (UTP)-induced increases of [Ca2+]i in A431 cells. Amlodipine besylate (30 μM) inhibits the store-operated Ca2+influx evoked by Thapsigargin in Fluo-3-loaded cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Amlodipine besylate | Cardiorex | Cordarene

Similar Products

  • Amlodipine besylate, (R)- [orb1698418]

    828247-64-9

    567.05

    C26H31ClN2O8S

    50 mg, 100 mg, 25 mg
  • Amlodipine besilate impurity B [orb1705293]

    721958-72-1

    570.033

    C29H32ClN3O7

    50 mg, 500 mg
  • Amlodipine besilate impurity D [orb1705295]

    92.72% (May vary between batches)

    113994-41-5

    406.86

    C20H23ClN2O5

    25 mg, 10 mg, 50 mg, 1 mg, 5 mg
  • Levamlodipine besylate [orb1302988]

    99.86% (May vary between batches)

    150566-71-5

    567.05

    C26H31ClN2O8S

    10 mg, 25 mg, 100 mg, 1 ml x 10 mM (in DMSO)
  • Amlodipine besylate monohydrate [orb1710735]

    532929-67-2

    585.07

    C26H33ClN2O9S

    25 mg, 100 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

500 mg
$ 70.00
1 g
$ 100.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry